<?xml version="1.0" encoding="UTF-8"?>
<p>Cardiovascular disorders (CVDs) are the leading cause of the global increase in mortality among individuals in developed [
 <xref rid="B91-molecules-25-02669" ref-type="bibr">91</xref>] and, more recently, in developing countries such as South Africa [
 <xref rid="B92-molecules-25-02669" ref-type="bibr">92</xref>]. CVDs and their risk factors include hypertension, myocardial infarction, angina pectoris, stroke, atherosclerosis, peripheral artery disease, and transient ischemic attack, to name but a few [
 <xref rid="B93-molecules-25-02669" ref-type="bibr">93</xref>]. Most of the disease burden caused by CVDs is borne by low- and middle-income countries. CVDs are mostly prevalent in middle-aged people [
 <xref rid="B94-molecules-25-02669" ref-type="bibr">94</xref>]. In the last few decades, there has been a dramatic increase in the prevalence of CVDs in South Africa [
 <xref rid="B95-molecules-25-02669" ref-type="bibr">95</xref>].
</p>
